Abstract Details
|
Michael V. Robers, MD
(Barrow Neurological Institute)
PRESENTER |
Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Robers has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Robers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Robers has received research support from Bristol Myers Squibb Foundation. |
| Harlori K. Bains, MD (Barrow Neurological Institute) | Dr. Bains has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. |
| Bill Jacobsen, MD (Barrow Neurological Institute) | No disclosure on file |
| Sana Aslam, DO (University of Colorado) | Dr. Aslam has nothing to disclose. |
| Robert J. Jackson, MD (Temecula Valley Hospital) | Dr. Jackson has nothing to disclose. |
| Edward Y. Chen, MD (Barrow Neurological Institute) | Dr. Chen has nothing to disclose. |
| Jennifer A. Heim, MD (Barrow Neurological Institute, Child Neurology) | No disclosure on file |
| Ganesh Murthy, MD | Dr. Murthy has nothing to disclose. |
| Aaron Zigelbaum, MD (International Multiple Sclerosis Management Practice) | No disclosure on file |
| Kerry L. Knievel, DO (Barrow Neurological Institute) | Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Knievel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . The institution of Dr. Knievel has received research support from Abbvie . |